BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8519034)

  • 1. Fluoxetine: a five-year review.
    Stokes PE
    Clin Ther; 1993; 15(2):216-43; discussion 215. PubMed ID: 8519034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
    Tulloch IF; Johnson AM
    J Clin Psychiatry; 1992 Feb; 53 Suppl():7-12. PubMed ID: 1531829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
    Tollefson GD; Sayler ME
    Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chairman's overview. The place of reboxetine in antidepressant therapy.
    Montgomery SA
    J Clin Psychiatry; 1998; 59 Suppl 14():26-9. PubMed ID: 9818628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine: a new serotonin reuptake inhibitor for the treatment of depression.
    Sherman TL; McDougle CJ; Price LH
    Conn Med; 1993 Sep; 57(9):587-92. PubMed ID: 8252846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in the treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1999; 60 Suppl 14():10-5; discussion 31-5. PubMed ID: 10408420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and safety: essentials in antidepressant pharmacotherapy.
    Lader MH
    J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of an acute antidepressant response to fluoxetine and sertraline.
    Flament MF; Lane RM; Zhu R; Ying Z
    Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects of serotonin reuptake inhibitors in the treatment of depressive illness.
    Burrows GD; McIntyre IM; Judd FK; Norman TR
    J Clin Psychiatry; 1988 Aug; 49 Suppl():18-22. PubMed ID: 3045107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy.
    Goodnick PJ
    Ann Clin Psychiatry; 2001 Mar; 13(1):31-41. PubMed ID: 11465683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of fluoxetine, a new serotonin-specific antidepressant.
    Boyer WF; Feighner JP
    Mt Sinai J Med; 1989 Mar; 56(2):136-40. PubMed ID: 2664482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine tenth anniversary update: the progress continues.
    Stokes PE; Holtz A
    Clin Ther; 1997; 19(5):1135-250. PubMed ID: 9385500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with serotonin reuptake inhibiting antidepressants.
    Mendels J
    J Clin Psychiatry; 1987 Mar; 48 Suppl():26-30. PubMed ID: 2950077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of new treatments for depression.
    Montgomery SA
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):3-6. PubMed ID: 3882678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.
    Harris MG; Benfield P
    Drugs Aging; 1995 Jan; 6(1):64-84. PubMed ID: 7696780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events and treatment discontinuations in fluoxetine clinical trials.
    Pande AC; Sayler ME
    Int Clin Psychopharmacol; 1993; 8(4):267-9. PubMed ID: 8277146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.